The effect of chemical sympathectomy and stress on bone remodeling in adult rats

Neuroendocrinology Letters

Volumn 31, Issue 6, 2010, Pages 807-813

  Hu, Kaijin ^a   Zhou, Hongzhi ^a   Zhang, Guoliang ^a   Qin, Ruifeng ^a   Hou, Rui ^a   Kong, Liang ^a   Ding, Yuxiang ^a  

^a Cadet Brigade School of Stomatology   (China)

Author keywords

6 hydroxydopamine; Bone remodeling; Stress; Sympathectomy

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM ION; NEUROPEPTIDE; NEUROTRANSMITTER; OXIDOPAMINE; PHOSPHORUS;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE REMODELING; CALCIUM BLOOD LEVEL; CANCELLOUS BONE; CHEMICAL SYMPATHECTOMY; CONTROLLED STUDY; FOOTSHOCK; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PHOSPHATE BLOOD LEVEL; RAT; STRESS; SYMPATHETIC NERVE;

EID: 79751497594     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Aberdeen J, Corr L, Milner P, Lincoln J, Burnstock G (1990). Marked increases in calcitonin gene-related peptide-containing nerves in the developing rat following long-term sympathectomy with guanethidine. Neuroscience. 35: 175-84. (Pubitemid 20113980)
2. Ahmed M, Bjurholm A, Kreicbergs A, Schultzberg M (1993). Neuropeptide Y, tyrosine hydroxylase and vasoactive intestinal polypeptide-immunoreactive nerve fibers in the vertebral bodies, discs, dura mater, and spinal ligaments of the rat lumbar spine. Spine (Phila Pa 1976). 18: 268-73.
3. Akopian A, Demulder A, Ouriaghli F, Corazza F, Fondu P, Bergmann P (2000). Effects of CGRP on human osteoclast-like cell formation: a possible connection with the bone loss in neurological disorders? Peptides. 21: 559-64.
4. Attacharya SK, Muruganandam A (2003). Adaptogenic activity of somnifera: an experimental study using a rat model of chronic stress. Pharmacol Biochem Behav. 75: 547-55.
5. Bjurholm A, Kreicbergs A, Terenius L, Goldstein M, Schultzberg M (1988). Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues. J Auton Nerv Syst. 25: 119-25. (Pubitemid 19057144)
6. Bonnet N, Brunet-Imbault B, Arlettaz A, Horcajada MN, Collomp K, Benhamou CL, Courteix D (2005). Alteration of trabecular bone under chronic beta2 agonists treatment. Med Sci Sports Exerc. 37: 1493-501. (Pubitemid 41368492)
7. Brain SD, Williams TJ, Tippins JR, Morris HR, Maclntyre I (1985). Calcitonin gene-related peptide is a potent vasodilator. Nature. 313: 54-6. (Pubitemid 15192304)
8. Cherruau M, Facchinetti P, Baroukh B, Saffar JL (1999). Chemical sympathectomy impairs bone resorption in rats: a role for the sympathetic system on bone metabolism. Bone. 25: 545-51. (Pubitemid 29469460)
9. Dietrich JW, Mundy GR, Raisz LG (1979). Inhibition of bone resorption in tissue culture by membrane-stabilizing drugs. Endocrinology. 104: 1644-8. (Pubitemid 9194111)
10. Donnerer J, Amann R, Lembeck F (1991). Neurogenic and non-neurogenic inflammation in the rat paw following chemical sympathectomy. Neuroscience. 45: 761-5.
11. D'Souza SM, MacIntyre I, Girgis SI, Mundy GR (1986). Human synthetic calcitonin gene-related peptide inhibits bone resorption in vitro. Endocrinology. 119: 58-61. (Pubitemid 16100707)
12. Elefteriou F. (2005a) Neuronal signaling and the regulation of bone remodeling. Cell Mol Life Sci. 62: 2339-49.
13. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G. (2005b) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 434: 514-20. (Pubitemid 40477060)
14. Esler MD, Turner AG, Kaye DM, Thompson JM, Kingwell BA, Morris M, Lambert GW, Jennings GL, Cox HS, Seals DR (1995). Aging effects on human sympathetic neuronal function. Am J Physiol. 268: 278-85.
15. Fristad I, Heyeraas KJ, Kvinnsland I (1994). Nerve fibres and cells immunoreactive to neurochemical markers in developing rat molars and supporting tissues. Arch Oral Biol. 39: 633-46.
16. Harada S, Rodan GA (2003). Control of osteoblast function and regulation of bone mass. Nature. 423: 349-55. (Pubitemid 40852710)
17. Hohmann EL, Levine L, Tashjian AH Jr (1983). Vasoactive intestinal peptide stimulates bone resorption via a cyclic adenosine 3′,5′- monophosphate-dependent mechanism. Endocrinology. 112: 1233-9.
18. Ishizuka K, Hirukawa K, Nakamura H, Togari A (2005). Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol. Neurosci Lett. 379: 47-51. (Pubitemid 40462396)
19. Kellenberger S, Muller K, Richener H, Bilbe G (1998). Formoterol and isoproterenol induce c-fos gene expression in osteoblast-like cells by activating beta2-adrenergic receptors. Bone. 22: 471-8. (Pubitemid 28226860)
20. Kondo A, Mogi M, Koshihara Y, Togari A (2001). Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochem Pharmacol. 61: 319-26. (Pubitemid 32126670)
21. Kondo A, Togari A (2003). In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse calvaria. Am J Physiol Endocrinol Metab. 285: E661-7.
22. Lerner UH (2002). Neuropeptidergic regulation of bone resorption and bone formation. J Musculoskelet Neuronal Interact. 2: 440-7.
23. Lerner UH, Lundberg P, Ransjö M, Persson P, Håkanson R (1994). Helodermin, helospectin, and PACAP stimulate cyclic AMP formation in intact bone, isolated osteoblasts, and osteoblastic cell lines. Calcif Tissue Int. 54: 284-9. (Pubitemid 24097831)
24. Lindblad BE, Nielsen LB, Jespersen SM, Bjurholm A, Bünger C, Hansen ES (1994). Vasoconstrictive action of neuropeptide Y in bone. The porcine tibia perfused in vivo. Acta Orthop Scand. 65: 629-34.
25. Lundberg P, Lie A, Bjurholm A, Lehenkari PP, Horton MA, Lerner UH, Ransjö M (2000). Vasoactive intestinal peptide regulates osteoclast activity via specific binding sites on both osteoclasts and osteoblasts. Bone. 27: 803-10.
26. Lundgaard A, Aalkjaer C, Bjurholm A, Mulvany MJ, Hansen ES (1997). Vasorelaxation in isolated bone arteries. Vasoactive intestinal peptide, substance P, calcitonin gene-related peptide, and bradykinin studied in pigs. Acta Orthop Scand. 68: 481-9.
27. McDonald JK (1988). NPY and related substances. Crit Rev Neurobiol. 4: 97-135.
28. Mione MC, Cavanagh JF, Kirkpatrick KA, Burnstock G (1992). Plasticity in expression of calcitonin gene-related peptide and substance P immunoreactivity in ganglia and fibres following guanethidine and/or capsaicin denervation. Cell Tissue Res. 268: 491-504.
29. Moore RE, Smith CK 2nd, Bailey CS, Voelkel EF, Tashjian AH Jr (1993). Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture. Bone Miner. 23: 301-15.
30. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987). Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 2: 595-610.
31. Sakhaee K, Nicar MJ, Glass K, Pak CY (1985). Postmenopausal osteoporosis as a manifestation of renal hypercalciuria with secondary hyperparathyroidism. J Clin Endocrinol Metab. 61: 368-73. (Pubitemid 15044274)
32. Schmitt CP, Obry J, Feneberg R, Veldhuis JD, Mehls O, Ritz E, Schaefer F (2003). Beta1-adrenergic blockade augments pulsatile PTH secretion in humans. J Am Soc Nephrol. 14: 3245-50. (Pubitemid 37509300)
33. Schon F, Ghatei M, Allen JM, Mulderry PK, Kelly JS, Bloom SR (1985). The effect of sympathectomy on calcitonin gene-related peptide levels in the rat trigeminovascular system. Brain Res. 348: 197-200. (Pubitemid 16235763)
34. Seals DR, Esler MD (2000). Human ageing and the sympathoadrenal system. J Physiol. 528: 407-17.
35. Serre CM, Farlay D, Delmas PD, Chenu C (1999). Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. Bone. 25: 623-9. (Pubitemid 29525427)
36. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G (2002). Leptin regulates bone formation via the sympathetic nervous system. Cell. 111: 305-17. (Pubitemid 35345151)
37. Takeuchi T, Tsuboi T, Arai M, Togari A (2001). Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. Biochem Pharmacol. 61: 579-86. (Pubitemid 32178492)
38. Togari A (2002). Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech. 58: 77-84.
39. Togari A, Arai M, Mizutani S, Mizutani S, Koshihara Y, Nagatsu T (1997). Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci Lett. 233: 125-8. (Pubitemid 27418180)
40. Togari A, Mogi M, Arai M, Yamamoto S, Koshihara Y (2000). Expression of mRNA for axon guidance molecules, such as semaphorin-III, netrins and neurotrophins, in human osteoblasts and osteoclasts. Brain Res. 878: 204-9.
41. Valentijn K, Gutow AP, Troiano N, Gundberg C, Gilligan JP, Vignery A (1997). Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats. Bone. 21: 269-74. (Pubitemid 27404084)
42. Zaidi M, Breimer LH, Maclntyre I. (1987a) Biology of peptides from the calcitonin genes. Q J Exp Physiol. 72: 371-408.
43. Zaidi M, Fuller K, Bevis PJ, GainesDas RE, Chambers TJ, MacIntyre I. (1987b) Calcitonin gene-related peptide inhibits osteoclastic bone resorption: a comparative study. Calcif Tissue Int. 40: 149-54.